CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 39.10
+0.30 (0.77%)
Sep 5, 2025, 1:17 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 8.24 billion as of September 5, 2025. Its market cap has decreased by -38.40% in one year.
Market Cap
8.24B
Enterprise Value
6.03B
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.10
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 8.24B, a decrease of -45.07%. That is a compound annual growth rate of -7.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 8.24B | -25.24% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | 4.57B | 3.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 394.73B |
| PharmaEssentia | 171.63B |
| Bora Pharmaceuticals Co., LTD. | 91.84B |
| Lotus Pharmaceutical | 51.15B |
| Lumosa Therapeutics | 40.18B |
| Oneness Biotech | 35.77B |
| Polaris Group | 29.31B |
| Center Laboratories | 28.67B |